<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><title>Trump’s watered-down Medicare drug pricing rule saves 96% less than initial proposal — Live Feed</title><link>https://www.live-feeds.com/feed/trump-s-watered-down-medicare-drug-pricing-rule-saves-96-less-than-initial-proposal</link><atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://www.live-feeds.com/feed/trump-s-watered-down-medicare-drug-pricing-rule-saves-96-less-than-initial-proposal/rss.xml" rel="self" type="application/rss+xml"/><description>Continuously updated, source-cited coverage.</description>
<item><title>Trump Administration Finalizes Medicare Drug Pricing Rule With Reduced Savings</title><link>https://www.live-feeds.com/feed/trump-s-watered-down-medicare-drug-pricing-rule-saves-96-less-than-initial-proposal</link><guid isPermaLink="false">https://www.live-feeds.com/feed/trump-s-watered-down-medicare-drug-pricing-rule-saves-96-less-than-initial-proposal#u103181</guid><pubDate>Mon, 05 Oct 2026 16:31:19 +0000</pubDate><description>The Trump administration finalized the GLOBE rule to lower Medicare Part B drug prices using a most-favored nation pricing model. The final rule is significantly more limited than the initial proposal, applying to only four companies. Medicare actuaries estimate the projected savings dropped from nearly $12 billion in the original proposal to $440 million, representing a 96% reduction in expected cost savings.Why it mattersThe rule aims to align US Medicare payments for certain drugs with lower prices paid in other developed nations. This effort targets high-cost prescriptions within the Part </description></item>
</channel></rss>